EFFECTIVENESS OF DRY SODIUM CHLORIDE INHALATION IN PULMONARY DISEASES – A MINIREVIEW

Halotherapy also known as salt therapy has its historical basis in respiratory health improvement and has evolved into modern therapeutic applications for pulmonary diseases. Sodium chloride inhalers and halogenerators create dry salt aerosols optimized for inhalation, targeting respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and post-COVID-19 complications. Mechanisms of action include improved bronchial mucus rheology, immune response enhancement, and reduction of bronchial obstruction. Clinical trials demonstrate significant benefits, including reduced respiratory symptoms, improved lung function, and extended remission periods. Portable devices, such as SaltMed and Salin devices, provide accessible halotherapy options, supporting the management of chronic lung conditions in diverse populations, including neonates and adults. Further exploration of halotherapy's applications in respiratory rehabilitation post-COVID-19 highlights its potential for broader implementation.